Battelle

Ohio
Pharmaceuticals Biotechnology and Life Sciences, Technology Hardware and Equipment

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Danger
High Risk

Summary:

Battelle scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Battelle increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Battelle forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. The company supports ESG within its business practices and prioritizes diversity in its recruitment and hiring. Battelle hosts unconscious bias training for its leadership and is a corporate partner of the National LGBT Chamber of Commerce. For these reasons, Battelle receives a High Risk rating.

Generate Reports
Clear
Toast